Sitagliptin and acute pancreatitis: cases and literature review.
Acute pancreatitis is the rapid onset inflammation of the pancreas. Medications are rare but important and rising cause of acute pancreatitis and account for approximately 2% of all cases. Sitagliptin is a potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of patients wi...
| Publicado en: | Turkiye Klinikleri Journal of Medical Sciences Vol. 32; no. 3; pp. 859 - 865 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | case study diagnostic images Journal Article |
| Publicado: |
Turkiye Klinikleri
Jun2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Sumario: | Acute pancreatitis is the rapid onset inflammation of the pancreas. Medications are rare but important and rising cause of acute pancreatitis and account for approximately 2% of all cases. Sitagliptin is a potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of patients with type 2 diabetes mellitus and acts by increasing active incretin hormone concentrations. Adverse effects including constipation, nausea, nasopharyngitis, urinary tract infection and dizziness were reported. We reported a case with acute pancreatitis that seems to be induced by sitagliptin. |
|---|